Showing results (131-140 of 166) with videos related to
Sort By:
Pageof 17
Cell Reports|November 23, 2022
Calreticulin mutations affect its chaperone function and perturb the glycoproteomePatrick M Schürch, Liliana Malinovska, Mohammad Hleihil, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinomaFederica Perrone, Simona Suardi, Elisa Pastore, et al.The Journal of Clinical Investigation|November 8, 2016
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progressionCecilia Dallavalle, Domenico Albino, Gianluca Civenni, et al.European Journal of Endocrinology|July 27, 2006
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumoursErika Hubina, Alexandra M Nanzer, Matthew R Hanson, et al.Plos One|March 23, 2013
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemiaAlessia Casolaro, Josee Golay, Clara Albanese, et al.European Journal of Endocrinology|November 30, 2006
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumorsEmanuele Ferrante, Monica Ferraroni, Tristana Castrignanò, et al.Journal of Neuro-Oncology|May 12, 2026
Stereotactic radiosurgery for pediatric craniopharyngiomas: a multicenter retrospective studyLuigi Albano, Marco Losa, Gaetano Giulio Vitale, et al.Nature Communications|December 13, 2016
Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescenceAjinkya Revandkar, Maria Luna Perciato, Alberto Toso, et al.The EMBO Journal|October 18, 2022
An arrayed genome-wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate-limiting for prion propagationMerve Avar, Daniel Heinzer, Alana M Thackray, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2011
Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumorsSara Madaschi, Madaschi Sara, Claudio Fiorino, et al.Pageof 17